These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9443712)

  • 1. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.
    Fassbender K; Schmidt R; Mössner R; Kischka U; Kühnen J; Schwartz A; Hennerici M
    Arch Neurol; 1998 Jan; 55(1):66-72. PubMed ID: 9443712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis.
    Grasser A; Möller A; Backmund H; Yassouridis A; Holsboer F
    Exp Clin Endocrinol Diabetes; 1996; 104(1):31-7. PubMed ID: 8750568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume.
    Schumann EM; Kümpfel T; Then Bergh F; Trenkwalder C; Holsboer F; Auer DP
    Ann Neurol; 2002 Jun; 51(6):763-7. PubMed ID: 12112083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroendocrine axis in patients with multiple sclerosis.
    Wei T; Lightman SL
    Brain; 1997 Jun; 120 ( Pt 6)():1067-76. PubMed ID: 9217689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.
    Melief J; de Wit SJ; van Eden CG; Teunissen C; Hamann J; Uitdehaag BM; Swaab D; Huitinga I
    Acta Neuropathol; 2013 Aug; 126(2):237-49. PubMed ID: 23812288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis.
    Heesen C; Gold SM; Raji A; Wiedemann K; Schulz KH
    Psychoneuroendocrinology; 2002 May; 27(4):505-17. PubMed ID: 11912002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis.
    Kern S; Schultheiss T; Schneider H; Schrempf W; Reichmann H; Ziemssen T
    Psychoneuroendocrinology; 2011 Nov; 36(10):1505-12. PubMed ID: 21621332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis.
    Kümpfel T; Schwan M; Weber F; Holsboer F; Trenkwalder C; Then Bergh F
    Psychoneuroendocrinology; 2014 Jul; 45():87-95. PubMed ID: 24845180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.
    Then Bergh F; Kümpfel T; Trenkwalder C; Rupprecht R; Holsboer F
    Neurology; 1999 Sep; 53(4):772-7. PubMed ID: 10489039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
    Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
    Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of cognitive dysfunction in multiple sclerosis.
    Heesen C; Schulz KH; Fiehler J; Von der Mark U; Otte C; Jung R; Poettgen J; Krieger T; Gold SM
    Brain Behav Immun; 2010 Oct; 24(7):1148-55. PubMed ID: 20621641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
    Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C
    Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.
    Then Bergh F; Kümpfel T; Grasser A; Rupprecht R; Holsboer F; Trenkwalder C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1610-5. PubMed ID: 11297592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis.
    Gottschalk M; Kümpfel T; Flachenecker P; Uhr M; Trenkwalder C; Holsboer F; Weber F
    Arch Neurol; 2005 Feb; 62(2):277-80. PubMed ID: 15710856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.